The epidemiology of perimenstrual psychological symptoms
- PMID: 11473504
- DOI: 10.1034/j.1600-0447.2001.00412.x
The epidemiology of perimenstrual psychological symptoms
Abstract
Objective: The purpose of this paper is to examine the prevalence, clinical significance and comorbidity of perimenstrual symptoms/syndrome (PERI-MS) in a community sample of women.
Method: Premenstrual and menstrual physical and psychological symptoms were assessed in a prospective longitudinal study of a representative community cohort of women (N=299) who were interviewed five times between the ages of 21 and 35 years.
Results: When classified according to the severity of distress, the prevalence rates were 8.1% for severe and 13.6% for moderate PERI-MS, respectively. Clinical indicators of severity were all greater among PERI-MS women with than without depressed mood.
Conclusion: The results of this study suggest that irritability, nervousness and tension irrespective of the presence of concomitant depressed mood are core elements of the perimenstrual syndrome.
Similar articles
-
Clinical Profiles of Premenstrual Experiences Among Women Having Premenstrual Syndrome (PMS): Affective Changes Predominate and Relate to Social and Occupational Functioning.Health Care Women Int. 2015;36(10):1104-23. doi: 10.1080/07399332.2014.954701. Epub 2014 Nov 3. Health Care Women Int. 2015. PMID: 25186770
-
A culturally sensitive study of premenstrual and menstrual symptoms among Chinese women.J Psychosom Obstet Gynaecol. 2009 Jun;30(2):105-14. doi: 10.1080/01674820902789241. J Psychosom Obstet Gynaecol. 2009. PMID: 19533490
-
Premenstrual symptoms and syndrome according to age at menarche in a 1982 birth cohort in southern Brazil.Cad Saude Publica. 2008 Apr;24(4):835-44. doi: 10.1590/s0102-311x2008000400014. Cad Saude Publica. 2008. PMID: 18392361
-
Epidemiology of premenstrual symptoms and disorders.Menopause Int. 2012 Jun;18(2):48-51. doi: 10.1258/mi.2012.012013. Menopause Int. 2012. PMID: 22611221 Review.
-
Perimenstrual symptoms: prevalence and risk factors.Psychosom Med. 1986 Jul-Aug;48(6):388-414. doi: 10.1097/00006842-198607000-00002. Psychosom Med. 1986. PMID: 3529156 Review.
Cited by
-
Premenstrual symptoms across the lifespan in an international sample: data from a mobile application.Arch Womens Ment Health. 2022 Oct;25(5):903-910. doi: 10.1007/s00737-022-01261-5. Epub 2022 Aug 26. Arch Womens Ment Health. 2022. PMID: 36018464 Free PMC article.
-
The role of hormones and hormonal treatments in premenstrual syndrome.CNS Drugs. 2003;17(5):325-42. doi: 10.2165/00023210-200317050-00003. CNS Drugs. 2003. PMID: 12665391 Review.
-
Effects of antidepressants on quality of life in women with premenstrual dysphoric disorder.Pharmacoeconomics. 2005;23(5):433-44. doi: 10.2165/00019053-200523050-00003. Pharmacoeconomics. 2005. PMID: 15896095 Review.
-
Premenstrual dysphoric disorder: burden of illness and treatment update.J Psychiatry Neurosci. 2008 Jul;33(4):291-301. J Psychiatry Neurosci. 2008. PMID: 18592027 Free PMC article.
-
Effects of Estrogen Therapy on the Serotonergic System in an Animal Model of Perimenopause Induced by 4-Vinylcyclohexen Diepoxide (VCD).eNeuro. 2018 Jan 22;5(1):ENEURO.0247-17.2017. doi: 10.1523/ENEURO.0247-17.2017. eCollection 2018 Jan-Feb. eNeuro. 2018. PMID: 29362726 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical